Chemical Compound
Gliclazide; N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methylbenzenesulfonamide; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Cyclopenta[c]pyrrole benzenesulfonamide deriv.; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diabezidum; Diabrezide; Diamicron; Diaprel; Glimicron; Glinormax; Glyzide; N-(4-Methylbenzenesulfonyl)-N'-[3-azabicyclo(3,3,0)oct-3-yl]urea; S 1702; S 852; SE 1702
CAS Registry Number
21187-98-4
Primary record
Gliclazide; N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methylbenzenesulfonamide; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Cyclopenta[c]pyrrole benzenesulfonamide deriv.; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diabezidum; Diabrezide; Diamicron; Diaprel; Glimicron; Glinormax; Glyzide; N-(4-Methylbenzenesulfonyl)-N'-[3-azabicyclo(3,3,0)oct-3-yl]urea; S 1702; S 852; SE 1702
- 库存
- 5,747 克
- 纯度
- 99.4 %
- CAS
- 21187-98-4
化合物标识与属性
- CAS
- 21187-98-4
- PubChem CID
- 3475
- SMILES
- CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
- Canonical SMILES
- Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1
名称与同义词
- gliclazide
- Glimicron
- Diamicron
- 21187-98-4
- Gliclazida
- Glyclazide
- Gliklazid
- Nordialex
- Diaikron
- Diabrezide
- Gliclazidum
- Novo Gliclazide
- Gen Gliclazide
- Gliclazide?
- diabezidum
- diabyl
- diaprel
- dizalid
- gliclazid
- glinormax
- glyzide
- Diamicron MR
- Benelaxa
- Crawnart
- Diaglico
- Glimiran
- Glutameal
- Kyowacron
- Ruimenia
- Ziclaseg
- Bilxona
- Diaglyk
- Edicil
- Glimil
- Glyade
- Zicron
- Unava
- Vamju
- Novo-Gliclazide
- Diabrezide;
- Gen-Gliclazide
- Glyclazide;
- Dacadis mr
- Diamicron;
- Glimicron;
- Nordialex;
- Nazdol mr
- Vitile xl
- Zicron pr
- Glimicron (TN)
- Mylan-Gliclazide
- Gliclazide CRS
- Gliclazide-d4
- Glimicron HA
- PMS-Gliclazide
- Diamicron (TN)
- Gliclazidum [INN-Latin]
- Gliclazida [INN-Spanish]
- Prestwick_869
- Dianorm (TN)
- Glubitor-OD (TN)
- Gliclazide (Standard)
- C15H21N3O3S
- Gliclazide (Diamicron)
- Spectrum_001478
- SpecPlus_000870
- DTXSID9023095
- Gliclazide (JAN/INN)
- Prestwick0_000558
- Prestwick1_000558
- Prestwick2_000558
- Prestwick3_000558
- RefChem:389010
- Spectrum3_001862
- Spectrum4_000598
- Spectrum5_000753
- G4PX8C4HKV
- CHEBI:31654
- D0M2MR
- Gliclazide (JP18/INN)
- AC1L1G0Q
- BOVGTQGAOIONJV-UHFFFAOYSA-N
- DTXCID003095
- SE 1702
- MFCD00409893
- SCHEMBL16387
- BSPBio_000635
- BSPBio_003304
- KBioGR_001096
- KBioSS_001958
- MLS001215197
- MLS001304077
- MLS001304118
- DivK1c_006966
- Gliclazide, powder, >=98%
- SPECTRUM1504145
- SPECTRUM1505013
- Gliclazide [BAN:INN:DCF:JAN]
- S-852
- SPBio_002556
- BPBio1_000699
- CHEMBL427216
- orb1308313
- NSC-758673
- S-1702
- CTK7G8576
- ERK5-6O07
- HY-B0753R
- J3.151H
- KBio1_001910
- KBio2_001958
- KBio2_004526
- KBio2_007094
- KBio3_002806
- SE-1702
- A10BB09
- CID3475
- Gliclazide (S1702; Diamicron)
- HMS1569P17
- HMS1922D15
- HMS2090K16
- HMS2096P17
- HMS2855P09
- HMS3656C22
- HMS3713P17
- HMS3744O13
- HMS5081J09
- Pharmakon1600-01504145
- S 1702
- S 852
- BCP21240
- CID:3475
- HY-B0753
- MSK10066
- EINECS 244-260-5
- Tox21_110590
- ANW-43362
- BBF-05867
- BBL012275
- BDBM50103512
- EBC-80093
- NSC758673
- NSC813216
- s2601
- SBB066074
- STK803142
- 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea
- S1702;SE1702
- S852
- AKOS003237903
- AKOS016340698
- Tox21_110590_1
- AB05958
- ACN-040058
- CCG-213918
- CS-2963
- DB01120
- FG23666
- KS-1067
- NSC-813216
- RP17658
- BRN 1657836
- 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
- NCGC00016751-01
- NCGC00095107-01
- NCGC00095107-02
- NCGC00095107-03
- NCGC00095107-04
- NCGC00095107-05
- NCGC00095107-06
- NCGC00095107-09
- NCGC00095107-10
- S1702
- 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea
- AC-12045
- AN-17308
- SMR000542971
- ST076805
- SBI-0052662.P002
- SID:134223040
- AB0012093
- AB1004595
- CAS-21187-98-4
- LS-160299
- 1-[3-Azabicyclo[3.3.0]oct-3-yl]-3-p-toluenesulfonylurea
- AB00053165
- AK00386162
- FT-0626712
- G0381
- NS00002064
- SW196994-3
- 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea
- D01599
- D83168
- K-6100
- AB00053165-09
- AB00053165_10
- AB00053165_11
- EN300-7359575
- N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea
- 1-[(4-methylbenzene)sulfonyl]-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea
- 187G984
- A815188
- D005907
- Q290001
- SR-01000816184
- 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(4-methylphenyl)sulfonyl]urea
- I06-0117
- N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide
- SR-01000816184-2
- SR-01000816184-3
- SR-01000816184-4
- Benzenesulfonamide,N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-
- BRD-A61154809-001-04-3
- BRD-A61154809-001-14-2
- BRD-A61154809-001-15-9
- BRD-A61154809-001-16-7
- N-((hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide
- 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea
- 1-(4-methylbenzenesulfonyl)-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea
- Benzenesulfonamide, N-(((hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)-4-methyl-
- Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-
- Gliclazide, British Pharmacopoeia (BP) Reference Standard
- Gliclazide, European Pharmacopoeia (EP) Reference Standard
- 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(p-tolylsulfonyl)urea
- 1-(3-Azabicyclo[3.3.0]octan-3-yl)-3-(4-methylphenylsulfonyl)urea
- N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide
- 1-((4-methylbenzene)sulfonyl)-3-(octahydrocyclopenta(c)pyrrol-2-yl)urea
- 3-{hexahydro-1H-cyclopenta[c]pyrrol-2-yl}-1-(4-methylbenzenesulfonyl)urea
- Urea, 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-
- Urea, 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-
- [(3-azabicyclo[3.3.0]oct-3-yl)amino]-N-[(4-methylphenyl)sulfonyl]carboxamide
- 1-(3,3a,4,5,6,6a-Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
- 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-((4-methylphenyl)sulfonyl)urea
- Gliclazide, 99%, whole-cell beta-cell ATP-sensitive potassium currents blocker - 25G 25g
- N-(3-azabicyclo[3.3.0]oct-3-yl){[(4-methylphenyl)sulfonyl]amino}carboxamide
- N-[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl]-4-methylbenzene-1-sulfonamide
- N-[[(H exahydrocylopenta[c]pyrrol-2(1H)-yl]amino]carbonyl ]-4-methylbenzenesulfonamide
- N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methylbenzenesulfonamide
- S-1702; S-852; S1702; S852; S 1702; S 852; SE1702
- 1185039-30-8
- 244-260-5
- BENZENESULFONAMIDE, N-[[(HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-4-METHYL
- Gliclazide; N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methylbenzenesulfonamide; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Cyclopenta[c]pyrrole benzenesulfonamide deriv.; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diabezidum; Diabrezide; Diamicron; Diaprel; Glimicron; Glinormax; Glyzide; N-(4-Methylbenzenesulfonyl)-N'-[3-azabicyclo(3,3,0)oct-3-yl]urea; S 1702; S 852; SE 1702
- N-[[3,3a,4,5,6,6a-Hexahydrocyclopenta[c]pyrrol-2(1H)-yl]aminocarbonyl]-4-methylbenzenesulfonamide